InvestorsHub Logo
Followers 57
Posts 11397
Boards Moderated 0
Alias Born 02/09/2009

Re: None

Monday, 11/14/2022 8:18:27 AM

Monday, November 14, 2022 8:18:27 AM

Post# of 547
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1®

https://ir.mymd.com/news-events/press-releases/detail/41/mymd-pharmaceuticals-announces-publication-of-phase-1-data

MYMD-1 demonstrated favorable safety and tolerability profile across multiple doses, with no clinically relevant adverse events, supporting advancement of the compound for Sarcopenia and Rheumatoid Arthritis.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News